Argonaute 2: A Novel Rising Star in Cancer Research
Open Access
- 1 January 2015
- journal article
- review article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 6 (9), 877-882
- https://doi.org/10.7150/jca.11735
Abstract
AGO2 (Argonaute 2, EIF2C2) is the only member in AGO family with catalytic activity and of extreme importance during small RNAs guided gene silencing processes. The structural investigations have provided insights into details and functional mechanisms of the four major domains within AGO2. As a multifunction player, AGO2 has been revealed involved in tumorgenesis through miRNAs-dependent or independent ways. And nowadays, AGO2 has also been more importantly found ectopically over-expressed in carcinomas and closely associated with aspects of cancers in means of interacting with well-known tumor factors. Here, we provide a review on structural insights, functional mechanisms, novel roles and relationship with carcinomas of AGO2.Keywords
This publication has 61 references indexed in Scilit:
- Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulationJournal of Hematology & Oncology, 2014
- MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinomaOncogenesis, 2014
- Tumour heterogeneity and cancer cell plasticityNature, 2013
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Up-regulation of Ago2 expression in gastric carcinomaMedical Oncology, 2013
- Argonaute Regulation: Two Roads to the Same DestinationDevelopmental Cell, 2013
- Argonaute-2-null embryonic stem cells are retarded in self-renewal and differentiationJournal of Biosciences, 2011
- Prolyl 4-hydroxylation regulates Argonaute 2 stabilityNature, 2008
- Angiogenesis: an organizing principle for drug discovery?Nature Reviews Drug Discovery, 2007
- Human Argonaute2 Mediates RNA Cleavage Targeted by miRNAs and siRNAsMolecular Cell, 2004